GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (OTCPK:MROPF) » Definitions » Net Income From Continuing Operations

MROPF (MicroPort CardioFlow Medtech) Net Income From Continuing Operations : $-7.35 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort CardioFlow Medtech Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. MicroPort CardioFlow Medtech's net income from continuing operations for the six months ended in Dec. 2024 was $0.62 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was $-7.35 Mil.

MicroPort CardioFlow Medtech Net Income From Continuing Operations Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Net Income From Continuing Operations Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income From Continuing Operations
Get a 7-Day Free Trial -60.88 -28.68 -64.73 -64.93 -6.35

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.62 -25.05 -40.91 -7.96 0.62

MicroPort CardioFlow Medtech Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-7.35 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort CardioFlow Medtech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (OTCPK:MROPF) » Definitions » Net Income From Continuing Operations
Comparable Companies
HKSE:01696 HKSE:02235 HKSE:06669 HKSE:06922 HKSE:02216 HKSE:02500 HKSE:06609 HKSE:02407 HKSE:02170 HKSE:09877 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
02160:Hong Kong 72X:Germany
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
Website
https://www.cardioflowmedtech.com
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.